AU4980200A - Methods and compositions for measuring ion channel conductance - Google Patents

Methods and compositions for measuring ion channel conductance

Info

Publication number
AU4980200A
AU4980200A AU49802/00A AU4980200A AU4980200A AU 4980200 A AU4980200 A AU 4980200A AU 49802/00 A AU49802/00 A AU 49802/00A AU 4980200 A AU4980200 A AU 4980200A AU 4980200 A AU4980200 A AU 4980200A
Authority
AU
Australia
Prior art keywords
compositions
methods
ion channel
channel conductance
measuring ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49802/00A
Other languages
English (en)
Inventor
Mitchell B. Berkenpas
Vincent E. Groppi Jr.
Mark L Wolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU4980200A publication Critical patent/AU4980200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Thin Film Transistor (AREA)
AU49802/00A 1999-05-27 2000-05-25 Methods and compositions for measuring ion channel conductance Abandoned AU4980200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13617499P 1999-05-27 1999-05-27
US60136174 1999-05-27
PCT/US2000/011862 WO2000073431A2 (en) 1999-05-27 2000-05-25 Methods and compositions for measuring ion channel conductance

Publications (1)

Publication Number Publication Date
AU4980200A true AU4980200A (en) 2000-12-18

Family

ID=22471672

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49802/00A Abandoned AU4980200A (en) 1999-05-27 2000-05-25 Methods and compositions for measuring ion channel conductance

Country Status (5)

Country Link
US (1) US20070238168A1 (enExample)
EP (1) EP1180142A2 (enExample)
JP (1) JP2003501022A (enExample)
AU (1) AU4980200A (enExample)
WO (1) WO2000073431A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214686B2 (en) 1997-06-30 2007-05-08 Targacept, Inc. Pharmaceutical compositions and methods for effecting dopamine release
EP1237923A2 (en) * 1999-12-14 2002-09-11 PHARMACIA & UPJOHN COMPANY Human ion channels
GB0003069D0 (en) * 2000-02-11 2000-03-29 Cambridge Drug Discovery Ltd Improved assay
DE10006309A1 (de) 2000-02-12 2001-08-23 Aventis Pharma Gmbh Verfahren zur Identifizierung von Substanzen, die die Aktivität von hyperpolarisationsaktivierten Kationen-kanälen modulieren
EP1381603A2 (en) 2000-08-18 2004-01-21 PHARMACIA & UPJOHN COMPANY Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6500840B2 (en) 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001284646A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002061074A1 (fr) * 2001-01-30 2002-08-08 Takeda Chemical Industries, Ltd. Nouvelle proteine et adn la comprenant
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
WO2003018585A1 (en) 2001-08-24 2003-03-06 Pharmacia & Upjohn Company Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
EP1432707B1 (en) 2001-10-02 2012-03-28 Pharmacia & Upjohn Company LLC Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
MXPA04004464A (es) 2001-11-08 2004-08-11 Upjohn Co Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
US6951868B2 (en) 2001-11-09 2005-10-04 Pfizer Inc. Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
JP2005522456A (ja) 2002-02-15 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Ｃｎｓ関連障害治療のためのアザビシクロ置換ベンゾイルアミドおよびチオアミド
US6858613B2 (en) 2002-02-19 2005-02-22 Pfizer Inc. Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
BR0307782A (pt) 2002-02-19 2005-01-04 Upjohn Co Compostos azabiciclo para o tratamento de doença
WO2003072578A1 (en) * 2002-02-20 2003-09-04 Pharmacia & Upjohn Company Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
AU2003267174A1 (en) 2002-05-09 2003-11-11 Memory Pharmaceuticals Corporation Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
US7176198B2 (en) 2002-08-01 2007-02-13 Pfizer Inc. 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
WO2004060917A2 (en) * 2003-01-07 2004-07-22 Neuromed Technologies, Inc. Fluorescence based t-type channel assay
ATE517176T1 (de) * 2004-10-15 2011-08-15 Monell Chemical Senses Centre Verfahren zur kultivierung von geschmackszellen aus säugern
CA2618700A1 (en) 2005-08-22 2007-03-01 Targacept, Inc. Heteroaryl-substituted diazatricycloalkanes, methods for its preparation and use thereof
JP5241255B2 (ja) * 2008-02-01 2013-07-17 生化学工業株式会社 関節痛の評価方法
WO2009140201A1 (en) 2008-05-12 2009-11-19 Targacept, Inc. Methods for preventing the development of retinopathy by the oral administration of nnr ligands
WO2010042799A2 (en) * 2008-10-09 2010-04-15 Howard Hughes Medical Institute Novel chimeric ligand-gated ion channels and methods of use thereof
PT2563904E (pt) 2010-04-26 2015-05-12 Novartis Ag Meio de cultura de células aperfeiçoado
IL274702B2 (en) 2017-11-27 2026-04-01 Coda Biotherapeutics Inc Compounds and methods for neurological diseases
CN111378025A (zh) * 2020-03-26 2020-07-07 集美大学 河豚毒素结合蛋白tfPSTBP2、核苷酸序列、其多克隆抗体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670113A (en) * 1991-12-20 1997-09-23 Sibia Neurosciences, Inc. Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same
GB2286397B (en) * 1993-03-08 1997-09-10 Salk Inst Biotech Ind Human neuronal nicotinic acetylcholine receptor compositions and methods of employing same
US6323000B2 (en) * 1996-12-20 2001-11-27 Clark A. Briggs Variant human α7 acetylcholine receptor subunit, and methods of production and uses thereof
US6103537A (en) * 1997-10-02 2000-08-15 Aclara Biosciences, Inc. Capillary assays involving separation of free and bound species

Also Published As

Publication number Publication date
US20070238168A1 (en) 2007-10-11
JP2003501022A (ja) 2003-01-14
WO2000073431B1 (en) 2001-07-19
WO2000073431A2 (en) 2000-12-07
WO2000073431A3 (en) 2001-05-03
EP1180142A2 (en) 2002-02-20

Similar Documents

Publication Publication Date Title
AU2002218496A1 (en) Method and device for measuring body compositions
AU2002224949A1 (en) Method and device for measuring levels
AU6026199A (en) Pulsed air sampler
AU2001271720A1 (en) Methods and compositions for determining gene function
AU2349399A (en) R-lansoprazole compositions and methods
AU5565099A (en) Pharmaceutical compositions and methods for use
AU5781800A (en) Methods and compositions for assaying analytes
AU2001286750A1 (en) Compositions and methods for exon profiling
AU4459301A (en) Ion concentration meter
AUPP479298A0 (en) Ion source
AU6295299A (en) Apparatus and chemical composition for maintaining atmospheric humidity
AU4867399A (en) Device for estimating volume
AU2000237154A1 (en) Method for detecting and killing epithelial cancer cells
AU2001290402A1 (en) Channel time calibration means
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU1049700A (en) Method and arrangement for measuring wood
AU3842900A (en) Method for evaluating distribution value of right and device used therefor
AU2433299A (en) Audio device
AUPP211498A0 (en) Method and means for moisture measurement
AU2002243285A1 (en) Auxiliary metering apparatus and methods
AU4896199A (en) Method and device for channel estimation
AU5243899A (en) Methods and compositions for using moclobemide
AU2001284557A1 (en) Apparatus and methods for analysing samples
AU2880699A (en) Pharmaceutical compositions and methods for use
AU3266299A (en) Sample diluter

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase